CHEBI:156534 - 2-[4-[(E)-2-(6,8-dichloro-2-phenyl-2H-chromen-3-yl)ethenyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name 2-[4-[(E)-2-(6,8-dichloro-2-phenyl-2H-chromen-3-yl)ethenyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane ChEBI ID CHEBI:156534 ChEBI ASCII Name 2-[4-[(E)-2-(6,8-dichloro-2-phenyl-2H-chromen-3-yl)ethenyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Definition A member of the class of chromenes that is 2H-chromene substituted at positions 2,3,6 and 8 by phenyl, 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethenyl, chloro and chloro groups, respectively. It is a potent retinoic acid receptor α agonist (Kd = 14nM) designed for the treatment of kidney disease. Stars This entity has been manually annotated by the ChEBI Team. Submitter Stan Laulederkind Supplier Information Download Molfile XML SDF Find compounds which contain this structure Find compounds which resemble this structure Take structure to the Advanced Search Formula C29H27BCl2O3 Net Charge 0 Average Mass 505.240 Monoisotopic Mass 504.14303 InChI InChI=1S/C29H27BCl2O3/c1-28(2)29(3,4)35-30(34-28)23-14-11-19(12-15-23)10-13-21-16-22-17-24(31)18-25(32)27(22)33-26(21)20-8-6-5-7-9-20/h5-18,26H,1-4H3/b13-10+ InChIKey NLWWGBDFLKSQIM-JLHYYAGUSA-N SMILES CC1(C)OB(OC1(C)C)C1=CC=C(\C=C\C2=CC3=CC(Cl)=CC(Cl)=C3OC2C2=CC=CC=C2)C=C1 Roles Classification Biological Role(s): retinoic acid receptor alpha/beta agonist Any retinoic acid receptor (RAR) agonist with specificity for RARalpha and RARbeta. (via 2-[4-[(E)-2-(6,8-dichloro-2-phenyl-2H-chromen-3-yl)ethenyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane ) Application(s): retinoic acid receptor alpha/beta agonist Any retinoic acid receptor (RAR) agonist with specificity for RARalpha and RARbeta. (via 2-[4-[(E)-2-(6,8-dichloro-2-phenyl-2H-chromen-3-yl)ethenyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane ) View more via ChEBI Ontology ChEBI Ontology Outgoing 2-[4-[(E)-2-(6,8-dichloro-2-phenyl-2H-chromen-3-yl)ethenyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CHEBI:156534) has role retinoic acid receptor α/β agonist (CHEBI:50741) 2-[4-[(E)-2-(6,8-dichloro-2-phenyl-2H-chromen-3-yl)ethenyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CHEBI:156534) is a benzenes (CHEBI:22712) 2-[4-[(E)-2-(6,8-dichloro-2-phenyl-2H-chromen-3-yl)ethenyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CHEBI:156534) is a boronate ester (CHEBI:50979) 2-[4-[(E)-2-(6,8-dichloro-2-phenyl-2H-chromen-3-yl)ethenyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CHEBI:156534) is a chromenes (CHEBI:23232) 2-[4-[(E)-2-(6,8-dichloro-2-phenyl-2H-chromen-3-yl)ethenyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CHEBI:156534) is a olefinic compound (CHEBI:78840) 2-[4-[(E)-2-(6,8-dichloro-2-phenyl-2H-chromen-3-yl)ethenyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CHEBI:156534) is a organochlorine compound (CHEBI:36683) IUPAC Name 6,8-dichloro-2-phenyl-3-{(E)-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethenyl}-2H-chromene Synonyms Sources 6,8-dichloro-2-phenyl-3-{(E)-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethenyl}-2H-1-benzopyran IUPAC BD-4 ChEBI BD4 SUBMITTER BJ-1 ChEBI BJ1 SUBMITTER Manual Xref Database US2019249259 Patent View more database links Citation Type Source 22125642 PubMed citation SUBMITTER Last Modified 22 October 2020